U.S. Healthcare Third-party Logistics Market Research Report
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Industry Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on U.S. Healthcare Third-party Logistics Market
5.1. COVID-19 Landscape: U.S. Healthcare Third-party Logistics Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. U.S. Healthcare Third-party Logistics Market, By Industry
8.1. U.S. Healthcare Third-party Logistics Market, by Industry, 2023-2032
8.1.1 Biopharmaceutical
8.1.1.1. Market Revenue and Forecast (2020-2032)
8.1.2. Pharmaceutical
8.1.2.1. Market Revenue and Forecast (2020-2032)
8.1.3. Medical Device
8.1.3.1. Market Revenue and Forecast (2020-2032)
Chapter 9. U.S. Healthcare Third-party Logistics Market, By Supply Chain
9.1. U.S. Healthcare Third-party Logistics Market, by Supply Chain, 2023-2032
9.1.1. Cold Chain
9.1.1.1. Market Revenue and Forecast (2020-2032)
9.1.2. Non-cold Chain
9.1.2.1. Market Revenue and Forecast (2020-2032)
Chapter 10. U.S. Healthcare Third-party Logistics Market, By Service Type
10.1. U.S. Healthcare Third-party Logistics Market, by Service Type, 2023-2032
10.1.1. Transportation
10.1.1.1. Market Revenue and Forecast (2020-2032)
10.1.2. Warehousing And Storage
10.1.2.1. Market Revenue and Forecast (2020-2032)
10.1.3. Others
10.1.3.1. Market Revenue and Forecast (2020-2032)
Chapter 11. U.S. Healthcare Third-party Logistics Market, Regional Estimates and Trend Forecast
11.1. U.S.
11.1.1. Market Revenue and Forecast, by Industry (2020-2032)
11.1.2. Market Revenue and Forecast, by Supply Chain (2020-2032)
11.1.3. Market Revenue and Forecast, by Service Type (2020-2032)
Chapter 12. Company Profiles
12.1. ShipMonk
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. DHL International.
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Cardinal Health.
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. MCKESSON CORPORATION
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Kuehne+Nagel
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. AmerisourceBergen Corporation
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. C.H. Robinson.
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. CEVA Logistics
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. Promptus, LLC.
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. FedEx
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
Chapter 13. Research Methodology
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix
14.1. About Us
14.2. Glossary of Terms
Cross-segment Market Size and Analysis for
Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers